Observational Study on Efficacy of Intensification of Insulin Therapy to at Least 3 Daily Injections in Type 2 Diabetes.
Phase of Trial: Phase IV
Latest Information Update: 09 Mar 2016
At a glance
- Drugs Insulin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms INTENSE3MIX
- Sponsors Novo Nordisk
- 01 May 2009 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 01 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Mar 2009 Actual patient number (113) added as reported by ClinicalTrials.gov.